Parabolic Drugs reports standalone net loss of Rs 28.04 crore in the September 2014 quarter

Explore Business Standard
Associate Sponsors
Co-sponsor

Sales decline 56.43% to Rs 49.63 crore
Net Loss of Parabolic Drugs reported to Rs 28.04 crore in the quarter ended September 2014 as against net loss of Rs 22.32 crore during the previous quarter ended September 2013. Sales declined 56.43% to Rs 49.63 crore in the quarter ended September 2014 as against Rs 113.91 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales49.63113.91 -56 OPM %-9.313.75 -PBDT-23.31-15.32 -52 PBT-40.57-32.31 -26 NP-28.04-22.32 -26Powered by Capital Market - Live News
First Published: Nov 15 2014 | 10:08 AM IST